PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 31 filers reported holding PROTARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $21,516 | -28.6% | 11,506 | -36.2% | 0.00% | – |
Q3 2023 | $30,138 | -48.6% | 18,047 | -26.5% | 0.00% | – |
Q2 2023 | $58,670 | +71448.8% | 24,548 | -6.7% | 0.00% | – |
Q1 2023 | $82 | +3.8% | 26,321 | -11.2% | 0.00% | – |
Q4 2022 | $79 | -99.9% | 29,626 | -41.0% | 0.00% | – |
Q3 2022 | $149,000 | -16.3% | 50,207 | -17.4% | 0.00% | – |
Q2 2022 | $178,000 | -51.9% | 60,784 | -16.0% | 0.00% | – |
Q1 2022 | $370,000 | -48.4% | 72,350 | -31.9% | 0.00% | – |
Q4 2021 | $717,000 | -1.2% | 106,245 | +1.3% | 0.00% | – |
Q3 2021 | $726,000 | -42.4% | 104,918 | -18.9% | 0.00% | -100.0% |
Q2 2021 | $1,260,000 | +33.1% | 129,380 | +115.2% | 0.00% | 0.0% |
Q1 2021 | $947,000 | -29.2% | 60,134 | +8.8% | 0.00% | 0.0% |
Q4 2020 | $1,338,000 | +109.7% | 55,259 | +45.7% | 0.00% | 0.0% |
Q3 2020 | $638,000 | +135.4% | 37,928 | +310.9% | 0.00% | – |
Q2 2020 | $271,000 | – | 9,230 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,304,262 | $5,299,803 | 1.21% |
STEMPOINT CAPITAL LP | 984,113 | $2,046,955 | 0.60% |
Velan Capital Investment Management LP | 480,000 | $998,400 | 0.57% |
CVI Holdings, LLC | 302,746 | $629,712 | 0.54% |
Privium Fund Management (UK) Ltd | 114,708 | $232,857 | 0.09% |
Boxer Capital, LLC | 811,627 | $1,688,184 | 0.09% |
Ikarian Capital, LLC | 180,712 | $375,881 | 0.06% |
RA Capital Management | 1,900,000 | $3,952,000 | 0.05% |
Baker Brothers Advisors | 536,832 | $1,116,611 | 0.01% |
ARMISTICE CAPITAL, LLC | 520,000 | $1,081,600 | 0.01% |